284 related articles for article (PubMed ID: 25309082)
1. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.
Cui XF; Zhou WM; Yang Y; Zhou J; Li XL; Lin L; Zhang HJ
World J Gastroenterol; 2014 Oct; 20(37):13521-9. PubMed ID: 25309082
[TBL] [Abstract][Full Text] [Related]
2. Visceral hypersensitivity in female but not in male serotonin transporter knockout rats.
Galligan JJ; Patel BA; Schneider SP; Wang H; Zhao H; Novotny M; Bian X; Kabeer R; Fried D; Swain GM
Neurogastroenterol Motil; 2013 Jun; 25(6):e373-81. PubMed ID: 23594365
[TBL] [Abstract][Full Text] [Related]
3. Effects of electroacupuncture on corticotropin-releasing hormone in rats with chronic visceral hypersensitivity.
Liu HR; Fang XY; Wu HG; Wu LY; Li J; Weng ZJ; Guo XX; Li YG
World J Gastroenterol; 2015 Jun; 21(23):7181-90. PubMed ID: 26109804
[TBL] [Abstract][Full Text] [Related]
4. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction.
Shi HL; Liu CH; Ding LL; Zheng Y; Fei XY; Lu L; Zhou XM; Yuan JY; Xie JQ
World J Gastroenterol; 2015 Apr; 21(16):4852-63. PubMed ID: 25944998
[TBL] [Abstract][Full Text] [Related]
5. Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats.
Yan C; Xin-Guang L; Hua-Hong W; Jun-Xia L; Yi-Xuan L
Braz J Med Biol Res; 2012 Oct; 45(10):948-54. PubMed ID: 22832600
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor upregulates serotonin transporter in human intestinal epithelial cells via transcriptional mechanisms.
Gill RK; Anbazhagan AN; Esmaili A; Kumar A; Nazir S; Malakooti J; Alrefai WA; Saksena S
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G627-36. PubMed ID: 21273531
[TBL] [Abstract][Full Text] [Related]
7. [Effect of changji'an on visceral hypersensitivity in rats with irritable bowel syndrome and its mechanism].
Zhu Q; Wang J; Lai HM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):813-7. PubMed ID: 19065896
[TBL] [Abstract][Full Text] [Related]
8. 5-HT
El-Ayache N; Galligan JJ
Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G132-G143. PubMed ID: 30359082
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.
Yang Y; Cui X; Chen Y; Wang Y; Li X; Lin L; Zhang H
J Physiol Pharmacol; 2014 Jun; 65(3):349-57. PubMed ID: 24930506
[TBL] [Abstract][Full Text] [Related]
10. Increased VGLUT3 involved in visceral hyperalgesia in a rat model of irritable bowel syndrome.
Yang CQ; Duan LP; Qiao PT; Zhao L; Guo LL
World J Gastroenterol; 2015 Mar; 21(10):2959-66. PubMed ID: 25780293
[TBL] [Abstract][Full Text] [Related]
11. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
12. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
Gao J; Xiong T; Grabauskas G; Owyang C
Gastroenterology; 2022 Jun; 162(7):1962-1974.e6. PubMed ID: 35167867
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
[TBL] [Abstract][Full Text] [Related]
14. TLR4 upregulates CBS expression through NF-κB activation in a rat model of irritable bowel syndrome with chronic visceral hypersensitivity.
Yuan B; Tang WH; Lu LJ; Zhou Y; Zhu HY; Zhou YL; Zhang HH; Hu CY; Xu GY
World J Gastroenterol; 2015 Jul; 21(28):8615-28. PubMed ID: 26229403
[TBL] [Abstract][Full Text] [Related]
15. NGF/PI3K/TRPV1 pathway mediates the regulation of visceral pain by acupuncture at "Shangjuxu" (ST37) in irritable bowel syndrome rats with chronic visceral hyperalgesia.
Chen CY; Yu Z; Ji F; He LL; Wang X; Xu B
Zhen Ci Yan Jiu; 2023 Oct; 48(10):1017-1024. PubMed ID: 37879952
[TBL] [Abstract][Full Text] [Related]
16. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
[TBL] [Abstract][Full Text] [Related]
17. LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS.
Zhang Y; Zhang H; Zhang W; Zhang Y; Wang W; Nie L
Cell Signal; 2020 Sep; 73():109674. PubMed ID: 32446903
[TBL] [Abstract][Full Text] [Related]
18. Role of nesfatin-1 in a rat model of visceral hypersensitivity.
Jia FY; Li XL; Li TN; Wu J; Xie BY; Lin L
World J Gastroenterol; 2013 Jun; 19(22):3487-93. PubMed ID: 23801843
[TBL] [Abstract][Full Text] [Related]
19. Female serotonin transporter-knockout rat: A potential model of irritable bowel syndrome.
Bi Z; Zhang S; Meng Y; Feng Y; Wang Y; Wang E; Pan X; Zhu R; Fan H; Pang S; Zhu L; Yuan J
FASEB J; 2021 Jul; 35(7):e21701. PubMed ID: 34143529
[TBL] [Abstract][Full Text] [Related]
20. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
Foley S; Garsed K; Singh G; Duroudier NP; Swan C; Hall IP; Zaitoun A; Bennett A; Marsden C; Holmes G; Walls A; Spiller RC
Gastroenterology; 2011 May; 140(5):1434-43.e1. PubMed ID: 21315720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
